Clinatec Endowment Fund raises awareness of biomedical research

What if light could be used as a drug? That’s the question asked on half of all Grenoble’s city buses over the course of a week this fall. The high-impact advertising campaign, run by the Clinatec Endowment Fund, was timed to coincide with World Alzheimer’s Day on September 21. The aim was simple: to raise public awareness of biomedical research, particularly in the field of neurodegenerative diseases.
An infrared illumination technique leveraging a CEA technology has shown a lot of potential, and three patients with Parkinson’s disease are currently receiving treatment under the NIR* protocol. The Clinatec Endowment Fund is also working on the pre-clinical phase of a new treatment for Alzheimer’s disease.

* Near Infra Red, a protocol run by Grenoble University Medical Center, in collaboration with the CEA, UGA and Boston Scientific.

Contact: thierry.bosc@cea.fr

Facebook

Twitter